The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregation
Andrew J. Holland and Don W. Cleveland
Find articles by Holland, A. in: JCI | PubMed | Google Scholar
Find articles by Cleveland, D. in: JCI | PubMed | Google Scholar
First published February 1, 2013 - More info
J Clin Invest. 2013;123(2):933–933. https://doi.org/10.1172/JCI68319.
© 2013 The American Society for Clinical Investigation
Related article:
Abstract
The mitotic checkpoint plays an important role in preventing chromosome segregation errors and the production of aneuploid progeny. In this issue, Zhang et al. examine mice and cells lacking the deubiquitinating enzyme USP44. Surprisingly, they find that USP44 prevents chromosome segregation errors through a function independent of its previously identified role in the mitotic checkpoint. Usp44-null animals develop aneuploidy and experience increased rates of tumorigenesis, implicating USP44 as novel tumor suppressor.
Authors
Andrew J. Holland, Don W. Cleveland
Original citation: J. Clin. Invest. 2012;122(12):4325–4328. doi:10.1172/JCI66420.
Citation for this erratum: J. Clin. Invest. 2013;123(2):933. doi:10.1172/JCI68319.
Figure 1 was incorrect.
The JCI regrets the error.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)